


The Fund aims to achieve both capital growth and an attractive level of income.
| Name | % Net Assets |
|---|---|
| Aberdeen Global II - Sterling Aggregateb | 17.5% |
| Sterling Bond Fund Z-1B | 15.7% |
| Dated Sterling Aggregate B | 4.6% |
| Aberdeen Global II - Dated Sterling AggregateB | 3.1% |
| HSBC | 2.8% |
| British American Tobacco | 2.6% |
| Royal Dutch Shell 'B' | 2.1% |
| GlaxoSmithKline | 2.1% |
| Centrica | 2.0% |
| ASTRAZENECA | 2.0% |
| Key | % Net Assets |
|---|---|
| 17.5% | |
| 15.7% | |
| 4.6% | |
| 3.1% | |
| 59.1% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 113.05p |
| Currency | GBP |
| Change | 0.12p |
| % | 0.11% |
| YTD change | 3.71p |
| YTD % | 3.39% |
| Fund Inception | 17/11/2006 |
|---|---|
| Fund Manager | Aberdeen Multi-Asset |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.25% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research